13 results on '"Michael James Gilhooley"'
Search Results
2. 'Genetic and clinical findings in an ethnically diverse retinitis pigmentosa cohort associated with pathogenic variants in EYS'
- Author
-
Morag Shanks, Susan M. Downes, Michael James Gilhooley, Stephanie Halford, Robert E MacLaren, Olivia Cundy, Penny Clouston, and Suzanne Broadgate
- Subjects
Adult ,Male ,Adolescent ,DNA Mutational Analysis ,Genes, Recessive ,Disease ,Biology ,Article ,Young Adult ,03 medical and health sciences ,Exon ,symbols.namesake ,0302 clinical medicine ,Gene duplication ,Retinitis pigmentosa ,medicine ,Humans ,Missense mutation ,Child ,Eye Proteins ,Genotyping ,Retrospective Studies ,Genetics ,Sanger sequencing ,Middle Aged ,medicine.disease ,Pedigree ,Ophthalmology ,Mutation ,030221 ophthalmology & optometry ,symbols ,Female ,Age of onset ,Retinitis Pigmentosa ,030217 neurology & neurosurgery - Abstract
Background and objectives: The EYS gene is an important cause of autosomal recessive retinitis pigmentosa (arRP). The objective of this study is to report on novel pathogenic variants in EYS and the range of associated phenotypes. Subjects and methods: This retrospective case series at a tertiary referral centre for inherited retinal diseases describes patients with an IRD and at least two variants in the EYS gene. Phenotyping included multimodal retinal imaging; genotyping molecular genetic analysis using targeted next generation sequencing. Sanger sequencing verification and analysis of novel variants using in silico approaches to determine their predicted pathogenicity. Results: Eight male and four female patients were included. Age at onset ranged from 11 to 62 years with variable symptom presentation; ten patients showed classical features of retinitis pigmentosa, albeit with great variation in disease severity and extent. Two patients had atypical phenotypes: one with localised inferior sector pigmentation and a mild RP phenotype with changes predominantly at the posterior pole. Eighteen variants in EYS were identified, located across the gene: six were novel. Eight variants were missense, two altered splicing, one was a whole exon duplication and the remainder were predicted to result in premature truncation of the protein. Conclusion: The marked variability in severity and age of onset in most patients in this ethnically diverse cohort adds to growing evidence that that mild phenotypes are associated with EYS variants. Similarly, the two atypical cases add to the growing diversity of EYS disease as do the six novel pathogenic variants described.
- Published
- 2020
- Full Text
- View/download PDF
3. ON-bipolar cell gene expression during retinal degeneration: implications for optogenetic visual restoration
- Author
-
Teele Palumaa, Stuart N. Peirson, Mark W. Hankins, Steven Hughes, Doron G. Hickey, Moritz Lindner, Michael James Gilhooley, and Robert E MacLaren
- Subjects
0301 basic medicine ,Retinal degeneration ,Yellow fluorescent protein ,Opsin ,Retinal Bipolar Cells ,Genetic Vectors ,Mice, Transgenic ,Biology ,Optogenetics ,Stem cell marker ,Real-Time Polymerase Chain Reaction ,Spermidine Synthase ,Article ,Viral vector ,03 medical and health sciences ,Cellular and Molecular Neuroscience ,chemistry.chemical_compound ,Mice ,0302 clinical medicine ,Contactin 1 ,Gene expression ,medicine ,Animals ,Annexin A7 ,Bipolar cell ,Retinal Degeneration ,Retinal ,Inherited retinal degeneration ,Dependovirus ,medicine.disease ,Flow Cytometry ,Immunohistochemistry ,Sensory Systems ,Cell biology ,Ophthalmology ,030104 developmental biology ,chemistry ,Gene Expression Regulation ,030221 ophthalmology & optometry ,biology.protein ,Female ,sense organs ,Sulfatases - Abstract
Purpose Retinal bipolar cells survive even in the later stages of inherited retinal degenerations (IRDs) and so are attractive targets for optogenetic approaches to vision restoration. However, it is not known to what extent the remodelling that these cells undergo during degeneration affects their function. Specifically, it is unclear if they are free from metabolic stress, receptive to adeno-associated viral vectors, suitable for opsin-based optogenetic tools and able to propagate signals by releasing neurotransmitter. Methods Fluorescence activated cell sorting (FACS) was performed to isolate labelled bipolar cells from dissociated retinae of litter-mates with or without the IRD mutation Pde6brd1/rd1 selectively expressing an enhanced yellow fluorescent protein (EYFP) as a marker in ON-bipolar cells. Subsequent mRNA extraction allowed Illumina® microarray comparison of gene expression in bipolar cells from degenerate to those of wild type retinae. Changes in four candidate genes were further investigated at the protein level using retinal immunohistochemistry over the course of degeneration. Results A total of sixty differentially expressed transcripts reached statistical significance: these did not include any genes directly associated with native primary bipolar cell signalling, nor changes consistent with metabolic stress. Four significantly altered genes (Srm2, Slf2, Anxa7 & Cntn1), implicated in synaptic remodelling, neurotransmitter release and viral vector entry had immunohistochemical staining colocalising with ON-bipolar cell markers and varying over the course of degeneration. Conclusion Our findings suggest relatively few gene expression changes in the context of degeneration: that despite remodelling, bipolar cells are likely to remain viable targets for optogenetic vision restoration. In addition, several genes where changes were seen could provide a basis for investigations to enhance the efficacy of optogenetic therapies., Highlights • Bipolar cells are attractive targets for therapeutic optogenetics in IRDs. • This is the first cell specific transcriptomic analysis of bipolar cells in an IRD model. • Bipolar cells maintain expression of genes essential to act as targets for optogenetics. • Protein staining relating to four candidate genes (Anxa7, Cntn1, Srm2, Sulf2) is confirmed using immunohistochemistry.
- Published
- 2021
- Full Text
- View/download PDF
4. From Transcriptomics to Treatment in Inherited Optic Neuropathies
- Author
-
Nicholas Owen, Michael James Gilhooley, Patrick Yu Wai Man, Mariya Moosajee, Gilhooley, Michael James [0000-0003-4109-5336], Owen, Nicholas [0000-0001-5598-6274], Moosajee, Mariya [0000-0003-1688-5360], and Apollo - University of Cambridge Repository
- Subjects
0301 basic medicine ,lcsh:QH426-470 ,Genotype ,genetic structures ,gene-therapy ,Genetic enhancement ,Central nervous system ,Glaucoma ,DOA ,Disease ,Review ,optic neuropathies ,Neuroprotection ,OPA1 ,Transcriptome ,03 medical and health sciences ,transcriptomics ,LHON ,0302 clinical medicine ,Atrophy ,Optic Atrophies, Hereditary ,Genetics ,medicine ,Animals ,Humans ,Genetic Predisposition to Disease ,Genetics (clinical) ,Alleles ,Genetic Association Studies ,business.industry ,Gene Expression Profiling ,Disease Management ,Genetic Therapy ,medicine.disease ,mitochondrial ,eye diseases ,lcsh:Genetics ,030104 developmental biology ,medicine.anatomical_structure ,Phenotype ,Retinal ganglion cell ,Mutation ,neuroprotection ,sense organs ,RNA-seq ,business ,Neuroscience ,030217 neurology & neurosurgery - Abstract
Inherited optic neuropathies, including Leber Hereditary Optic Neuropathy (LHON) and Dominant Optic Atrophy (DOA), are monogenetic diseases with a final common pathway of mitochondrial dysfunction leading to retinal ganglion cell (RGC) death and ultimately loss of vision. They are, therefore, excellent models with which to investigate this ubiquitous disease process—implicated in both common polygenetic ocular diseases (e.g., Glaucoma) and late-onset central nervous system neurodegenerative diseases (e.g., Parkinson disease). In recent years, cellular and animal models of LHON and DOA have matured in parallel with techniques (such as RNA-seq) to determine and analyze the transcriptomes of affected cells. This confluence leaves us at a particularly exciting time with the potential for the identification of novel pathogenic players and therapeutic targets. Here, we present a discussion of the importance of inherited optic neuropathies and how transcriptomic techniques can be exploited in the development of novel mutation-independent, neuroprotective therapies.
- Published
- 2021
- Full Text
- View/download PDF
5. Expression and Localization of Kcne2 in the Vertebrate Retina
- Author
-
A. Jennifer Morton, Teele Palumaa, Mark W. Hankins, Moritz Lindner, Michael James Gilhooley, Steven Hughes, Morton, Jennifer [0000-0003-0181-6346], and Apollo - University of Cambridge Repository
- Subjects
0301 basic medicine ,genetic structures ,Kcne2 ,Macaque ,Synapse ,Transcriptome ,Songbirds ,chemistry.chemical_compound ,Mice ,Mirp1 ,0302 clinical medicine ,Retinal Rod Photoreceptor Cells ,Zebrafish ,Microscopy, Confocal ,biology ,ion channels ,photoreceptors ,Immunohistochemistry ,Cell biology ,medicine.anatomical_structure ,Potassium Channels, Voltage-Gated ,Retinal Cone Photoreceptor Cells ,bipolar cells ,Retinal Bipolar Cells ,ribbon-synapse ,Outer plexiform layer ,CHO Cells ,Transfection ,MinK-related peptide 1 ,03 medical and health sciences ,Cricetulus ,biology.animal ,medicine ,Animals ,Retina ,Sheep ,Computational Biology ,Retinal ,biology.organism_classification ,Macaca mulatta ,Mice, Inbred C57BL ,030104 developmental biology ,chemistry ,Gene Expression Regulation ,Synapses ,sense organs ,Visual Neuroscience ,030217 neurology & neurosurgery ,Immunostaining - Abstract
Purpose: To characterize the retinal expression and localization of Kcne2, an ancillary (β) ion-channel subunit with an important role in fine-tuning cellular excitability. Methods: We analyzed available single-cell transcriptome data from tens of thousands of murine retinal cells for cell-type-specific expression of Kcne2 using state-of-the-art bioinformatics techniques. This evidence at the transcriptome level was complemented with a comprehensive immunohistochemical characterization of mouse retina (C57BL/6, ages 8–12 weeks) employing co-labeling techniques and cell-type-specific antibody markers. We furthermore examined how conserved the Kcne2 localization pattern in the retina was across species by performing immunostaining on zebrafish, cowbird, sheep, mice, and macaque. Results: Kcne2 is distinctly expressed in cone photoreceptors and rod bipolar cells. At a subcellular level, the bulk of Kcne2 immunoreactivity can be observed in the outer plexiform layer. Here, it localizes into cone pedicles and likely the postsynaptic membrane of the rod bipolar cells. Thus, the vast majority of Kcne2 immunoreactivity is observed in a thin band in the outer plexiform layer. In addition to this, faint Kcne2 immunoreactivity can also be observed in cone inner segments and the somata of a small subset of cone ON bipolar cells. Strikingly, the localization of Kcne2 in the outer plexiform layer was preserved among all of the species studied, spanning at least 300 million years of evolution of the vertebrate kingdom. Conclusions: The data we present here suggest an important and specific role for Kcne2 in the highly specialized photoreceptor-bipolar cell synapse.
- Published
- 2020
6. Idiopathic Acquired Temporal Wedge Visual Field Defects
- Author
-
Michael James Gilhooley, Clare L. Fraser, Simon J. Hickman, Sui Wong, and Gordon T. Plant
- Subjects
medicine.medical_specialty ,genetic structures ,Glaucoma ,03 medical and health sciences ,0302 clinical medicine ,Optical coherence tomography ,Ophthalmology ,medicine ,Monocular ,medicine.diagnostic_test ,business.industry ,Blind spot ,Original Articles ,medicine.disease ,Optic disc drusen ,eye diseases ,Visual field ,medicine.anatomical_structure ,030221 ophthalmology & optometry ,Optometry ,sense organs ,Neurology (clinical) ,business ,030217 neurology & neurosurgery ,Electroretinography ,Optic disc - Abstract
Our aim is to report 13 unusual cases of acquired, temporal sectoral scotomas. Such stationary “wedge” field defects have been reported previously in cases of presumed congenital nasal hypoplasia of the optic disc and as a complication of vitreoretinal surgery. To our knowledge, the literature provides no reports of similar defects occurring spontaneously. This is a descriptive clinical case series of 13 patients presenting with sub-acute monocular temporal visual field loss. All were clinically assessed and investigated with Goldmann perimetry, automated Humphrey visual fields, retinal optical coherence tomography, orbital ultrasound, and standard and multi-focal electroretinography. Cases were followed with serial perimetry for a mean of 3.9 years (range: 6 months to 10 years). Goldmann and Humphrey perimetry both demonstrated “wedge”-shaped defects extending temporally from an apex contiguous with, or lateral to, the blind spot. There was no evidence of optic disc drusen, glaucoma, disc hypoplasia, or focal retinitis. Sectoral optic disc swelling was not present in any patient at presentation. In all cases, the visual field defect remained stable. One patient developed a similar defect in the fellow eye after an interval of 5 years. Here we describe 13 cases of acquired, stationary temporal wedge scotomas, novel in the literature. Although the aetiology is uncertain, we propose damage to the nasal rim of the optic disc as a likely mechanism.
- Published
- 2016
- Full Text
- View/download PDF
7. Bell’s palsy
- Author
-
Michael James Gilhooley and Abigail Davis
- Subjects
medicine.medical_specialty ,Palsy ,Unilateral facial weakness ,business.industry ,Neurological function ,medicine.disease ,Facial nerve ,Surgery ,03 medical and health sciences ,0302 clinical medicine ,Bell's palsy ,Paralysis ,medicine ,Prednisolone ,Motor neurone ,030212 general & internal medicine ,medicine.symptom ,030223 otorhinolaryngology ,business ,medicine.drug - Abstract
Bell’s palsy is an idiopathic lower motor neurone palsy of the facial nerve. It is the most common cause of rapid-onset unilateral facial weakness, affecting approximately 1 in 5000 patients in the UK each year. A careful history and examination can usually exclude other causes of facial nerve paralysis. Seventy-one percent of affected patients regain full neurological function within a year. Timely treatment with prednisolone increases the likelihood of complete recovery. Ocular complications may occur if the patient cannot completely close the affected eye. This may be prevented by regular use of lubricants. Patients who do not recover nerve function may benefit from surgery to improve facial function and appearance.
- Published
- 2016
- Full Text
- View/download PDF
8. Acute intermittent porphyria leading to posterior reversible encephalopathy syndrome (PRES): a rare cause of abdominal pain and seizures
- Author
-
Michael James Gilhooley and Andrew Dagens
- Subjects
0301 basic medicine ,Adult ,medicine.medical_specialty ,Abdominal pain ,Porphyrins ,Nausea ,030105 genetics & heredity ,Gastroenterology ,Article ,03 medical and health sciences ,Seizures ,Internal medicine ,Haem biosynthesis ,medicine ,Humans ,Acute intermittent porphyria ,business.industry ,Posterior reversible encephalopathy syndrome ,General Medicine ,medicine.disease ,Magnetic Resonance Imaging ,Abdominal Pain ,Porphyria ,Posterior Leukoencephalopathy Syndrome ,Anesthesia ,Porphyria, Acute Intermittent ,Female ,Headaches ,medicine.symptom ,business - Abstract
Acute intermittent porphyria (AIP) is an inherited deficiency in the haem biosynthesis pathway. AIP is rare, affecting around 1 in 75 000 people. Acute attacks are characterised by abdominal pain associated with autonomic, neurological and psychiatric symptoms. AIP is rarely associated with posterior reversible encephalopathy syndrome (PRES). PRES is a clinicoradiological condition caused by the failure of the posterior circulation to autoregulate, resulting in cerebral oedema, headaches, nausea and seizures. This association is important because drugs used in the management of seizures may worsen an attack of AIP. This article describes a case of AIP and PRES in a young woman.
- Published
- 2016
9. Rhythmic expression of per1 in the dentate gyrus is suppressed by corticosterone: implications for neurogenesis
- Author
-
Michael James Gilhooley, Joe Herbert, and S. B. Pinnock
- Subjects
Male ,endocrine system ,medicine.medical_specialty ,Neurogenesis ,Central nervous system ,Hippocampus ,Cell Count ,Biology ,chemistry.chemical_compound ,Corticosterone ,Internal medicine ,medicine ,Animals ,Circadian rhythm ,Drug Implants ,Suprachiasmatic nucleus ,General Neuroscience ,Dentate gyrus ,Stem Cells ,Period Circadian Proteins ,Circadian Rhythm ,Rats ,Endocrinology ,medicine.anatomical_structure ,nervous system ,chemistry ,Dentate Gyrus ,Suprachiasmatic Nucleus ,Rats, Transgenic ,PER1 - Abstract
The stimulating action of anti-depressant drugs on the number of mitotic cells on the dentate gyrus on the adult rat depends on an intact diurnal rhythm of corticosterone. This suggests that there may be a clock mechanism in the dentate gyrus which is sensitive to corticoids. This paper reports the diurnal expression the 'clock' gene per1 in the dentate gyrus, and how it is altered by clamping the diurnal rhythm in corticosterone. We show that there is a diurnal rhythm in the number of mitotic progenitor cells in the dentate gyrus of the hippocampus in adult male per1-luciferase rats, approximately 6 h out of phase with the plasma corticosterone rhythm. This is suppressed by clamping the daily corticosterone levels by a subcutaneous implant of corticosterone (100 mg). There was also a daily rhythm of per1 expression in both suprachiasmatic nucleus (SCN) and the dentate gyrus, which were in phase with one another. The per1 rhythm in the dentate gyrus, but not the SCN, was suppressed by clamping the plasma corticosterone rhythm. These results are related to the previous finding that clamping the corticosterone rhythm also prevents the stimulating action of fluoxetine and other controlling agents on the mitotic activity of the progenitor cells.
- Published
- 2010
10. Recurrent presumed herpes simplex keratitis and episcleritis in keratosis follicularis (Darier's disease)
- Author
-
Michael James Gilhooley, Chris Panos, Charles Claoué, and Meera Radia
- Subjects
Male ,medicine.medical_specialty ,Article ,Keratitis ,Cornea ,Desmosome ,medicine ,Darier's disease ,Humans ,Simplexvirus ,Keratosis follicularis ,Skin ,Corneal epithelium ,business.industry ,Mucous membrane ,General Medicine ,Episcleritis ,Middle Aged ,medicine.disease ,Dermatology ,eye diseases ,medicine.anatomical_structure ,Chronic Disease ,Keratitis, Herpetic ,Dry Eye Syndromes ,sense organs ,business ,Darier Disease ,Scleritis - Abstract
Keratosis follicularis (Darier's disease) is an autosomal dominant dermatological disorder characterised by abnormal epidermal differentiation and loss of normal cell-to-cell adhesion. Cardinal features include diffuse hyperkeratotic warty papules with scaly plaques in seborrhoeic regions with associated mucous membrane changes. Darier's disease is rare (prevalence 2.7 in 100 000), with few ocular sequelae reported: commonly dry eye with or without Sjögren's syndrome. This is the first report, to the best of our knowledge, to describe a case of recurrent herpes simplex virus (HSV) keratitis and episcleritis in a 47-year-old man suffering from Darier's disease. The patient's condition predisposed him towards developing ocular complications due to several factors: impaired desmosome function leading to poor cell-to-cell adhesion in the corneal epithelium, dry eye and HSV invasion of inflamed periocular skin presumably combining to allow viral colonisation of a poorly protected cornea.
- Published
- 2015
- Full Text
- View/download PDF
11. P03-89 - How are large scale studies of medication influencing change in our treatment strategies for schizophrenia?
- Author
-
Michael James Gilhooley, R. Zaman, A. Davis, and M. Agius
- Subjects
medicine.medical_specialty ,Schizophrenia (object-oriented programming) ,Clinical study design ,medicine.medical_treatment ,Outcome measures ,Discontinuation ,Psychiatry and Mental health ,Observer Bias ,Scale (social sciences) ,medicine ,Treatment strategy ,Psychology ,Psychiatry ,Antipsychotic ,Clinical psychology - Abstract
BackgroundMany studies have recently been carried out to compare the effectiveness of various antipsychotic agents.Aims and ObjectivesWe wished to determine what could be learnt from these studies about the effectiveness of antipsychotics, and whether this should influence choice of treatment.MethodWe carried out a literature search using PUBMED. We directed special attention to large studies comparing medications in schizophrenia. These studies included CUTLASS, CATIE, SOHO, CAFE, and EUFEST (Kahn 2008, Haro 2006, Jones 2006, Lieberman 2005, Perkins 2008), as well as studies by Tihonen 92006, 2009) The studies were critically reviewed.ResultsThe different studies measure different aspects of care, at different phases of the illness. This illustrates the need to study schizophrenia through a stage model. Furthermore, different outcome measures are proposed. We believe that discontinuation data, on which some studiesdepend, is a weak measure of effectiveness. Important doubts arise regarding the choice of patients (those requiring switching of antipsychotic) in CUTLASS, and also regarding potential observer bias in this study.ConclusionThere is much information to be gathered from the results of such studies. However interpretation is made more difficult by problems within the study designs themselves. On balance it does appear that different antipsychotics have different effectiveness. The main difficulty in putting these results into practice is concern among clinicians and patients regarding side effects.
- Published
- 2010
- Full Text
- View/download PDF
12. P.3.a.023 What do large scale studies of medication in schizophrenia add to our management strategies?
- Author
-
Michael James Gilhooley, S. Chapman, Rashid Zaman, and Mark Agius
- Subjects
Pharmacology ,Psychiatry and Mental health ,medicine.medical_specialty ,Neurology ,Scale (ratio) ,Schizophrenia (object-oriented programming) ,medicine ,Pharmacology (medical) ,Neurology (clinical) ,Psychiatry ,Psychology ,Biological Psychiatry - Published
- 2009
- Full Text
- View/download PDF
13. How to Involve Undergraduate Medical Students in Psychiatric Research
- Author
-
H. Pepper, C. Kelly, Catherine F. Slattery, A. Kilsby, V. Bradley, Mark Agius, A. Davis, D. Ryan, Z. Rashid, Michael James Gilhooley, and H. Wear
- Subjects
Clinical audit ,medicine.medical_specialty ,Medical education ,Medical curriculum ,business.industry ,Audit ,Unit (housing) ,Psychiatry and Mental health ,Research based ,ComputingMilieux_COMPUTERSANDEDUCATION ,medicine ,Psychiatry ,business - Abstract
The poster will address the important issue of how we can use opportunities in teaching our medical students how to take a wider view of psychiatry and learn to ‘think outside the box’ thus broadening their vision, enabling them to challenge presently held concepts, while at the same time learning the basic tenets of our profession.Clearly, this is done by involving our students in clinical research based and audit based activities. However not all schools or teachers are comfortable with doing this, while the medical curriculum is broad, and there is a risk that students ‘only study for exams’.Research based activities, including simple things such as using basic it skills to do a literature search for a review article or carrying out a useful clinical audit, using a unit held database, are however things which students can easily do, and these can lead to publishable case reports, posters, or ever articles in peer reviewed journals.The poster will illustrate how we developed research activities with students at Cambridge University Clinical School. It shall discuss the advantages, difficulties, and indeed enjoyment of carrying out such activities.
- Published
- 2009
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.